Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

Q: What does CUSIP G7709Q104 represent in this 13F holders report?

CUSIP G7709Q104 is the security identifier for RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in Q3 2021?

226 institutional investors reported RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share for Q3 2021. Use the holders table for investor-level position and value details.

CUSIP: G7709Q104

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding: 424,966,351
Total 13F shares: 265,367,304
Share change: +15,158,111
Total reported value: $9,590,727,932
Put/Call ratio: 23%
Price per share: $36.14
Number of holders: 226
Value change: +$538,289,516
Number of buys: 122
Number of sells: 114

Quarterly Holders Quick Answers

What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP G7709Q104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MORGAN STANLEY	13F	Company	12%	50,794,041	$2,082,049,000	—	30 Jun 2021	13F
VANGUARD GROUP INC	13F	Company	5.7%	24,342,200	$997,787,000	—	30 Jun 2021	13F
FMR LLC	13F	Company	5.7%	24,095,928	$987,693,000	—	30 Jun 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	5.3%	22,721,815	$931,367,000	—	30 Jun 2021	13F
Capital International Investors	13F	Company	4%	16,942,708	$694,482,000	—	30 Jun 2021	13F
BlackRock Finance, Inc.	13F	Company	2.4%	10,287,641	$421,691,000	—	30 Jun 2021	13F
Vantage Consulting Group Inc	13F	Company	2.2%	9,302,445	$381,307,000	—	30 Jun 2021	13F
JPMORGAN CHASE & CO	13F	Company	1.7%	7,315,001	$299,842,000	—	30 Jun 2021	13F
HARVARD MANAGEMENT CO INC	13F	Company	1.7%	7,142,856	$292,786,000	—	30 Jun 2021	13F
SIGULER GUFF ADVISERS, LLC	13F	Company	1.6%	6,761,970	$277,173,000	—	30 Jun 2021	13F
STATE STREET CORP	13F	Company	1.1%	4,867,634	$199,524,000	—	30 Jun 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1%	4,303,526	$176,402,000	—	30 Jun 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.88%	3,745,414	$153,525,000	—	30 Jun 2021	13F
VIKING GLOBAL INVESTORS LP	13F	Company	0.76%	3,238,654	$132,752,000	—	30 Jun 2021	13F
Amundi	13F	Individual	0.67%	2,828,265	$115,929,000	—	30 Jun 2021	13F
NORGES BANK	13F	Company	0.66%	2,794,952	$114,565,000	—	30 Jun 2021	13F
Sloan Kettering Cancer Center Memorial	13F	Individual	0.63%	2,680,644	$109,880,000	—	30 Jun 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.52%	2,199,853	$90,172,000	—	30 Jun 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.47%	1,984,686	$81,224,000	—	30 Jun 2021	13F
Aberdeen Group plc	13F	Company	0.44%	1,884,011	$77,235,000	—	30 Jun 2021	13F
William E. Ford	3/4/5	Director	— class O/S missing	2,586,134	$71,241,786	—	30 Jun 2021	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.37%	1,592,554	$65,278,000	—	30 Jun 2021	13F
TimesSquare Capital Management, LLC	13F	Company	0.35%	1,501,560	$61,549,000	—	30 Jun 2021	13F
GENERAL ATLANTIC, L.P.	13F	Individual	0.35%	1,500,000	$61,485,000	—	30 Jun 2021	13F
Legal & General Group Plc	13F	Company	0.35%	1,471,237	$60,306,000	—	30 Jun 2021	13F
EATON VANCE MANAGEMENT	13F	Company	0.33%	1,383,073	$56,692,000	—	30 Jun 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.32%	1,352,176	$55,427,000	—	30 Jun 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.3%	1,254,498	$51,422,000	—	30 Jun 2021	13F
NORTHERN TRUST CORP	13F	Company	0.29%	1,218,491	$49,946,000	—	30 Jun 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.28%	1,194,882	$48,978,000	—	30 Jun 2021	13F
Bank of New York Mellon Corp	13F	Company	0.23%	993,306	$40,716,000	—	30 Jun 2021	13F
ROBERT WOOD JOHNSON FOUNDATION	13F	Company	0.23%	970,151	$39,766,000	—	30 Jun 2021	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.23%	970,006	$39,761,000	—	30 Jun 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.23%	964,101	$39,519,000	—	30 Jun 2021	13F
Capital International, Inc./CA/	13F	Company	0.2%	838,074	$34,353,000	—	30 Jun 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.19%	828,600	$33,964,000	—	30 Jun 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.18%	759,200	$31,120,000	—	30 Jun 2021	13F
Overbrook Management Corp	13F	Company	0.18%	757,121	$31,034,000	—	30 Jun 2021	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	729,377	$29,897,000	—	30 Jun 2021	13F
HOMESTEAD ADVISERS CORP	13F	Company	0.17%	720,240	$29,523,000	—	30 Jun 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.17%	715,172	$29,315,000	—	30 Jun 2021	13F
Swiss National Bank	13F	Company	0.17%	714,510	$29,288,000	—	30 Jun 2021	13F
Indie Asset Partners, LLC	13F	Company	0.17%	711,623	$29,169,000	—	30 Jun 2021	13F
Invesco Ltd.	13F	Company	0.16%	693,518	$28,427,000	—	30 Jun 2021	13F
UBS Group AG	13F	Company	0.16%	669,544	$27,445,000	—	30 Jun 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.15%	619,939	$25,411,000	—	30 Jun 2021	13F
COOPER INVESTORS PTY LTD	13F	Company	0.14%	600,501	$24,614,536	—	30 Jun 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.13%	573,435	$23,505,102	—	30 Jun 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.13%	571,384	$23,421,000	—	30 Jun 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.12%	489,351	$20,058,000	—	30 Jun 2021	13F

Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q3 2021

As of 30 Sep 2021, Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by 226 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 265,367,304 shares. The largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, BlackRock Inc., Berkshire Hathaway Inc, Vantage Consulting Group Inc, HARVARD MANAGEMENT CO INC, SIGULER GUFF ADVISERS, LLC, and STATE STREET CORP. This page lists 226 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

229

Q3 2021 holders

226

Holder diff

-3

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.